Janney Montgomery Scott’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $10.1M | Buy |
13,078
+1,845
| +16% | +$1.41M | 0.03% | 584 |
|
|
2025
Q4 | $8.67M | Sell |
11,233
-4,533
| -29% | -$3.08M | 0.02% | 674 |
|
|
2025
Q3 | $8.87M | Buy |
15,766
+3,176
| +25% | +$1.8M | 0.02% | 662 |
|
|
2025
Q2 | $6.61M | Sell |
12,590
-15,452
| -55% | -$8.62M | 0.02% | 713 |
|
|
2025
Q1 | $17.8M | Buy |
28,042
+4,976
| +22% | +$3.42M | 0.05% | 366 |
|
|
2024
Q4 | $16.4M | Buy |
23,066
+4,130
| +22% | +$3.47M | 0.05% | 394 |
|
|
2024
Q3 | $19.9M | Sell |
18,936
-1,073
| -5% | -$1.19M | 0.06% | 345 |
|
|
2024
Q2 | $21M | Sell |
20,009
-6,898
| -26% | -$6.69M | 0.06% | 310 |
|
|
2024
Q1 | $25.9M | Buy |
26,907
+2,593
| +11% | +$2.47M | 0.08% | 261 |
|
|
2023
Q4 | $21.4M | Buy |
24,314
+6,485
| +36% | +$5.34M | 0.07% | 283 |
|
|
2023
Q3 | $14.7M | Buy |
17,829
+1,216
| +7% | +$956K | 0.05% | 326 |
|
|
2023
Q2 | $11.9M | Buy |
16,613
+1,144
| +7% | +$882K | 0.04% | 409 |
|
|
2023
Q1 | $12.7M | Buy |
15,469
+10,163
| +192% | +$7.67M | 0.05% | 344 |
|
|
2022
Q4 | $3.83M | Buy |
5,306
+1,299
| +32% | +$958K | 0.01% | 767 |
|
|
2022
Q3 | $2.76M | Sell |
4,007
-2,072
| -34% | -$1.3M | 0.01% | 835 |
|
|
2022
Q2 | $3.61M | Sell |
6,079
-15,723
| -72% | -$10.2M | 0.02% | 698 |
|
|
2022
Q1 | $15.2M | Sell |
21,802
-2,165
| -9% | -$1.37M | 0.07% | 277 |
|
|
2021
Q4 | $15.1M | Sell |
23,967
-2,766
| -10% | -$1.7M | 0.06% | 290 |
|
|
2021
Q3 | $16.2M | Buy |
26,733
+813
| +3% | +$505K | 0.07% | 251 |
|
|
2021
Q2 | $14.5M | Buy |
25,920
+1,697
| +7% | +$860K | 0.06% | 283 |
|
|
2021
Q1 | $11.5M | Buy |
24,223
+13,693
| +130% | +$6.67M | 0.06% | 305 |
|
|
2020
Q4 | $5.09M | Sell |
10,530
-1,947
| -16% | -$1.05M | 0.02% | 538 |
|
|
2020
Q3 | $6.98M | Buy |
12,477
+2,521
| +25% | +$1.53M | 0.04% | 380 |
|
|
2020
Q2 | $6.21M | Buy |
9,956
+1,707
| +21% | +$969K | 0.04% | 388 |
|
|
2020
Q1 | $4.03M | Buy |
8,249
+1,348
| +20% | +$556K | 0.03% | 451 |
|
|
2019
Q4 | $2.59M | Buy |
6,901
+3,988
| +137% | +$1.34M | 0.02% | 687 |
|
|
2019
Q3 | $808K | Sell |
2,913
-5,363
| -65% | -$1.59M | 0.01% | 1132 |
|
|
2019
Q2 | $2.59M | Sell |
8,276
-695
| -8% | -$231K | 0.02% | 629 |
|
|
2019
Q1 | $3.68M | Buy |
8,971
+3,949
| +79% | +$1.63M | 0.03% | 496 |
|
|
2018
Q4 | $1.88M | Sell |
5,022
-594
| -11% | -$217K | 0.02% | 661 |
|
|
2018
Q3 | $2.27M | Buy |
5,616
+1,075
| +24% | +$409K | 0.02% | 653 |
|
|
2018
Q2 | $1.57M | Buy |
4,541
+336
| +8% | +$105K | 0.02% | 773 |
|
|
2018
Q1 | $1.45M | Sell |
4,205
-542
| -11% | -$189K | 0.01% | 800 |
|
|
2017
Q4 | $1.78M | Buy |
4,747
+32
| +0.7% | +$13K | 0.02% | 693 |
|
|
2017
Q3 | $2.11M | Sell |
4,715
-1,562
| -25% | -$743K | 0.02% | 593 |
|
|
2017
Q2 | $3.08M | Buy |
6,277
+1,628
| +35% | +$712K | 0.04% | 436 |
|
|
2017
Q1 | $1.8M | Buy |
4,649
+2,009
| +76% | +$745K | 0.02% | 595 |
|
|
2016
Q4 | $969K | Buy |
2,640
+813
| +44% | +$309K | 0.01% | 788 |
|
|
2016
Q3 | $734K | Buy |
+1,827
| New | +$733K | 0.01% | 786 |
|
|
2016
Q2 | – | Sell |
-986
| Closed | -$355K | – | 1068 |
|
|
2016
Q1 | $355K | Sell |
986
-1,377
| -58% | -$567K | 0.01% | 895 |
|
|
2015
Q4 | $1.28M | Sell |
2,363
-416
| -15% | -$225K | 0.03% | 475 |
|
|
2015
Q3 | $1.29M | Sell |
2,779
-226
| -8% | -$121K | 0.04% | 450 |
|
|
2015
Q2 | $1.53M | Buy |
3,005
+164
| +6% | +$80K | 0.03% | 589 |
|
|
2015
Q1 | $1.28M | Buy |
2,841
+2,094
| +280% | +$887K | 0.02% | 753 |
|
|
2014
Q4 | $306K | Buy |
+747
| New | +$294K | 0.01% | 1677 |
|
|
2014
Q2 | – | Sell |
-896
| Closed | -$269K | – | 2247 |
|
|
2014
Q1 | $269K | Sell |
896
-436
| -33% | -$134K | 0.01% | 1529 |
|
|
2013
Q4 | $367K | Buy |
+1,332
| New | +$383K | 0.01% | 1295 |
|
Other funds holding REGN
VCM
N
Janney Montgomery Scott's REGN Position: Q1 2026 in Review
Janney Montgomery Scott increased its Regeneron Pharmaceuticals (REGN) stake by 16% in Q1 2026, buying an estimated $1.41M and bringing the position to 13,078 shares worth $10.1M. The position accounts for 0.03% of the portfolio, ranked #584.
Janney Montgomery Scott first reported a position in REGN in Q4 2013 and has held it in 47 quarters since. The position peaked at $25.9M in Q1 2024. 1,392 funds tracked by Wall St. Rank hold REGN as of Q1 2026.
- Janney Montgomery Scott held 13,078 shares of Regeneron Pharmaceuticals worth $10.1M as of Q1 2026.
- Janney Montgomery Scott bought 1,845 Regeneron Pharmaceuticals shares in Q1 2026, an estimated $1.41M.
- Regeneron Pharmaceuticals made up 0.03% of Janney Montgomery Scott's portfolio in Q1 2026, its #584 holding.
- Janney Montgomery Scott first reported a position in Regeneron Pharmaceuticals in Q4 2013 and has held it in 47 quarters since.
- Janney Montgomery Scott's Regeneron Pharmaceuticals position peaked at $25.9M in Q1 2024.
- 1,392 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2026.
Based on Janney Montgomery Scott's 13F filing for Q1 2026, filed 22 Apr 2026.